Market revenue in 2023 | USD 79.0 million |
Market revenue in 2030 | USD 139.3 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.37% in 2023. Horizon Databook has segmented the South Korea implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
As the Korea Heart Disease Fact Sheet 2020 highlights, numerous adults in Korea suffer from hypertension, hypercholesterolemia, and obesity. CVD risk factors tend to increase as people age, with more than 58% of adults aged 70 or older having two or more risk factors.
This growing burden of CVDs and associated risk factors is expected to boost the demand for ICD devices, driving the growth in the South Korean market. Moreover, there is a significant focus on research and development activities in the field of CVDs in South Korea.
The government and private healthcare organizations are introducing new devices and initiatives to expand care reach and improve treatment options, contributing to the growth of the ICD device market. In addition, South Korea is facing a rapidly aging population.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into South Korea implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account